Cullinan Therapeutics, Inc. (CGEM)
10.97
+0.24
(+2.24%)
USD |
NASDAQ |
Jan 14, 10:26
Cullinan Therapeutics Market Cap: 648.07M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 15.20M |
| AIM ImmunoTech, Inc. | 3.618M |
| IGC Pharma, Inc. | 28.40M |
| NovaBay Pharmaceuticals, Inc. | 1.532B |
| Protalix Biotherapeutics, Inc. | 159.23M |
Market Cap Related Metrics
| PEG Ratio | -0.1073 |
| Price to Book Value | 1.441 |
| Price | 11.01 |
| Earnings Yield | -33.43% |
| PEGY Ratio | -0.1073 |